Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine

NCT00140348 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

BIOLOGICAL: Immunotherapy allogeneic GM-CSF secreting cellular vaccine

Sponsor

Cell Genesys